Research progress on the mechanism of N6-methyladenosine methylation modification and proteolipid protein 1 gene in schizophrenia

Journal of Translational Neuroscience ›› 2022, Vol. 7 ›› Issue (1) : 6 -10.

PDF (5715KB)
Journal of Translational Neuroscience ›› 2022, Vol. 7 ›› Issue (1) : 6 -10. DOI: 10.3868/j.issn.2096-0689.2022.01.002
Special Topic: Research Progress of Schizophrenia Related Genes
Special Topic: Research Progress of Schizophrenia Related Genes

Research progress on the mechanism of N6-methyladenosine methylation modification and proteolipid protein 1 gene in schizophrenia

Author information +
History +
PDF (5715KB)

Abstract

Schizophrenia (SCZ) is a serious mental illness with unknown etiology, high recurrence rate and high disability rate, which has caused a great burden to individuals and society. There is no clear etiology and pathogenesis. Methylation of N6-methyladenosine (m6A) can regulate the nervous and mental system, and affect the function of the nervous system. Proteolipid protein 1 (PLP1) is a risk gene for schizophrenia. In this study we review the research progress on the pathogenesis of schizophrenia, m6A methylation, and PLP1 gene.

Keywords

schizophrenia (SCZ) / methylation of N6-methyladenosine (m6A) / proteolipid protein 1 (PLP1)

Cite this article

Download citation ▾
null. Research progress on the mechanism of N6-methyladenosine methylation modification and proteolipid protein 1 gene in schizophrenia. Journal of Translational Neuroscience, 2022, 7(1): 6-10 DOI:10.3868/j.issn.2096-0689.2022.01.002

登录浏览全文

4963

注册一个新账户 忘记密码

References

AI Summary AI Mindmap
PDF (5715KB)

1302

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/